5-Bromo-2,3,3-trimethyl-3H-pyrrolo[2,3-b]pyridine, 97.0%, 5g

3-Bromo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 5g

N1-(4-Chlorobenzyl)-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride, 95.0%, 250mg

1-(2-fluorobenzyl)-4-piperidinamine dihydrochloride hydrate, 95.0%, 5g

2-(Diphenylphosphino)ethanaminium tetrafluoroborate, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 15 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

2-CHLORO-4-(DIETHYLAMINO)PYRIDO[3,2-D]PYRIMIDINE, 97.0%, 1g

4-(Hydroxymethyl)-1-benzylpyrrolidin-2-one, 97.0%, 5g

5-BROMO-2-METHYL-3-(PROPAN-2-YL)-2H-INDAZOLE, 95%, 100mg

(S)-4-((tert-Butoxycarbonyl)amino)-4-phenylbutanoic acid, 97.0%, 1g

methyl 4-(hydroxymethyl)bicyclo[2.2.1]heptane-1-carboxylate, 95.0%, 1g

2,5-Dioxopyrrolidin-1-yl 6-(3-bromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate, 250mg

Ethyl 1-methyl-2-oxocyclopentanecarboxylate, 97%, 10g